The Business Research Company’s Oral Contraceptive Pills Global Market Report 2021: COVID-19 Growth And Change
LONDON, GREATER LONDON, UK, March 1, 2021 /EINPresswire.com/ — New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
Read More On The Global Oral Contraceptive Pills Market Report: https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
The high incidence of unintended pregnancies is expected to drive the growth of the generic oral contraceptive pills market over the coming years. An unintended pregnancy is a pregnancy that is always unwanted, such as a pregnancy where no children have been planned. The University of California, San Francisco (UCSF) study shows that the rates of unwanted pregnancy and abortion declined substantially when women received a one-year prescription of oral contraceptives. According to the World Health Organization (WHO), 74 million women living in low middle-income economies register unplanned pregnancies every year globally. The WHO’s research noticed 4,794 women had an unplanned pregnancy after they had discontinued using contraceptives. Therefore, the need to avoid unintended pregnancies drives the growth of the oral contraceptive pills market.
The global oral contraceptive pills market size is expected to grow from $16.51 billion in 2020 to $18.36 billion in 2021 at a compound annual growth rate (CAGR) of 11.19%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The contraceptive drugs market is expected to reach $95.04 billion in 2025 at a CAGR of 7.63%.
The oral contraceptive pills market by type into combination, progestin only, others, by category into generic, branded, by distribution channel into hospital pharmacy, retail pharmacy, clinics, online channel, public channel and NGO, others.
The major players covered in the global oral contraceptive pills market are Teva Pharmaceutical Industries Ltd, Bayer AG, Syzygy Healthcare, Mankind Pharma Ltd., Pfizer Inc., Piramal Enterprises Ltd., Ferring B.V, Merck & Co. Inc., Johnson & Johnson, Lupin Pharmaceuticals Inc, V Care Pharma, HLL Life Care, Sopharma AD, Sanofi S.A., Amneal Pharmaceuticals LLC, Abbvie Inc. (Allergan PLC), Aurobindo Pharma Limited.
Oral Contraceptive Pills Global Market Report 2021: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides oral contraceptive pills market overview, forecast oral contraceptive pills market size and growth for the whole market, oral contraceptive pills market segments, and geographies, oral contraceptive pills market trends, oral contraceptive pills market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Oral Contraceptive Pills Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp
Here Is A List Of Similar Reports By The Business Research Company:
Hormonal Contraceptives Global Market Report 2021: COVID 19 Impact and Recovery to 2030
Fetal And Neonatal Monitoring Devices Global Market Report 2021: COVID 19 Impact and Recovery to 2030
Gynecologists Global Market Report 2018
Family Planning Centers Global Market Report 2018
Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Source: EIN Presswire